Janoshik COA Third-Party Testing [COA links for the 5-Amino-1MQ 50mg lyo batch to be added once Janoshik testing is complete]
Powder lasts years
Canine conditions or diseases in which diet composition may have an effect on disease progression or outcome include kidney disease, foodborne and environmental allergies, neurologic conditions, pancreatitis, bladder stones, dysbiosis/chronic inflammatory intestinal disease, metabolic diseases (eg, diabetes mellitus), liver disease, joint disease, and dental disease
Lower starting doses also help distinguish peptide effects from coincidental events
Following the 2015 acquisition, the brand name, NDC registrations and product lines have been uninterrupted
BPC-157 is an FDA Category 2 substance